tiprankstipranks
Trending News
More News >
Celon Pharma SA (PL:CLN)
:CLN
Poland Market

Celon Pharma SA (CLN) Financial Statements

Compare
0 Followers

Celon Pharma SA Financial Overview

Celon Pharma SA's market cap is currently zł1.13B. The company's EPS TTM is zł0.068; its P/E ratio is 68.85; and it has a dividend yield of 0.43%. Celon Pharma SA is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is zł―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuezł 176.62Mzł 213.92Mzł 161.91Mzł 196.09Mzł 157.45M
Gross Profitzł 113.45Mzł 147.10Mzł 95.45Mzł 134.37Mzł 107.26M
Operating Incomezł -36.81Mzł -27.24Mzł -69.76Mzł -10.45Mzł -3.67M
EBITDAzł 14.96Mzł 32.71Mzł 9.32Mzł 27.81Mzł 30.37M
Net Incomezł -34.45Mzł -28.12Mzł -39.28Mzł -11.61Mzł -917.00K
Balance Sheet
Cash & Short-Term Investmentszł 56.52Mzł 114.54Mzł 164.62Mzł 227.55Mzł 43.98M
Total Assetszł 543.79Mzł 569.31Mzł 608.93Mzł 707.14Mzł 703.64M
Total Debtzł 16.93Mzł 25.59Mzł 26.82Mzł 14.92Mzł 25.48M
Net Debtzł 8.65Mzł -6.77Mzł -56.08Mzł -132.88Mzł -20.91M
Total Liabilitieszł 98.59Mzł 123.75Mzł 129.29Mzł 153.14Mzł 268.97M
Stockholders' Equityzł 445.21Mzł 445.56Mzł 479.65Mzł 554.00Mzł 344.53M
Cash Flow
Free Cash Flowzł -34.13Mzł -41.13Mzł -38.61Mzł 2.60Mzł -28.26M
Operating Cash Flowzł -11.34Mzł -8.31Mzł -4.70Mzł 43.95Mzł 70.90M
Investing Cash Flowzł -7.49Mzł -21.64Mzł -31.47Mzł -121.05Mzł -98.53M
Financing Cash Flowzł 13.32Mzł -20.59Mzł -28.72Mzł 180.91Mzł 4.25M
Currency in PLN

Celon Pharma SA Earnings and Revenue History

Celon Pharma SA Debt to Assets

Celon Pharma SA Cash Flow

Celon Pharma SA Forecast EPS vs Actual EPS